Published in Eur J Cancer Prev on April 01, 2002
Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors. Clin Cancer Res (2008) 4.02
Contemporary epidemiology of renal cell cancer. Cancer J (2008) 2.40
Prospective evaluation of analgesic use and risk of renal cell cancer. Arch Intern Med (2011) 2.34
Fat, protein, and meat consumption and renal cell cancer risk: a pooled analysis of 13 prospective studies. J Natl Cancer Inst (2008) 1.81
Survival after diagnosis of localized T1a kidney cancer: current population-based practice of surgery and nonsurgical management. Urology (2013) 1.51
Association between R.E.N.A.L. nephrometry score and perioperative outcomes following open partial nephrectomy under cold ischemia. Can Urol Assoc J (2014) 1.38
Contemporary epidemiology of renal cell carcinoma: perspectives of primary prevention. World J Urol (2010) 1.24
Pseudogene PTENP1 functions as a competing endogenous RNA to suppress clear-cell renal cell carcinoma progression. Mol Cancer Ther (2014) 1.21
Antiangiogenic therapy for advanced renal cell carcinoma: management of treatment-related toxicities. Invest New Drugs (2012) 1.13
Alcohol intake and renal cell cancer risk: a meta-analysis. Br J Cancer (2012) 1.13
LINE-1 methylation levels in leukocyte DNA and risk of renal cell cancer. PLoS One (2011) 1.11
Efficacy and safety of axitinib versus sorafenib in metastatic renal cell carcinoma: subgroup analysis of Japanese patients from the global randomized Phase 3 AXIS trial. Jpn J Clin Oncol (2013) 1.10
Increasing detection and increasing incidence in thyroid cancer. World J Surg (2009) 1.09
Current status of targeted therapy for advanced renal cell carcinoma. Korean J Urol (2012) 1.02
Metabotropic glutamate receptor 1 (Grm1) is an oncogene in epithelial cells. Oncogene (2012) 1.01
Hypertension is the primary component of metabolic syndrome associated with pathologic features of kidney cancer. World J Urol (2016) 1.01
Renal cell cancer among African Americans: an epidemiologic review. BMC Cancer (2011) 1.01
Epigenetic regulation in RCC: opportunities for therapeutic intervention? Nat Rev Urol (2012) 0.99
Alcohol intake and risk of renal cell carcinoma: a meta-analysis of published case-control studies. Arch Med Sci (2011) 0.99
Analgesic use and the risk of kidney cancer: a meta-analysis of epidemiologic studies. Int J Cancer (2013) 0.96
Epidemiologic characteristics and risk factors for renal cell cancer. Clin Epidemiol (2009) 0.95
Renal cancer paradox: higher incidence but not higher mortality among African-Americans. Eur J Cancer Prev (2011) 0.95
Trends in incidence, mortality, and survival for kidney cancer in Canada, 1986-2007. Cancer Causes Control (2014) 0.95
Cancers of the urinary tract among American Indians and Alaska Natives in the United States, 1999-2004. Cancer (2008) 0.94
Dietary supplementation of silymarin protects against chemically induced nephrotoxicity, inflammation and renal tumor promotion response. Invest New Drugs (2009) 0.93
An analysis of growth, differentiation and apoptosis genes with risk of renal cancer. PLoS One (2009) 0.93
Targeted therapy in renal cancer. Ther Adv Med Oncol (2009) 0.92
Fish, vitamin D, and flavonoids in relation to renal cell cancer among smokers. Am J Epidemiol (2009) 0.91
Quality of life in patients with advanced renal cell carcinoma treated with temsirolimus or interferon-alpha. Br J Cancer (2010) 0.90
Menstrual and reproductive factors and risk of renal cell cancer in the Multiethnic Cohort. Cancer Epidemiol Biomarkers Prev (2009) 0.90
Therapy of mRCC beyond mTOR-inhibition in clinical practice: results of a retrospective analysis. J Cancer Res Clin Oncol (2014) 0.88
Race and sex disparities in the treatment of older patients with T1a renal cell carcinoma: a comorbidity-controlled competing-risks model. Urol Oncol (2014) 0.86
The efficacy and safety of irreversible electroporation for the ablation of renal masses: a prospective, human, in-vivo study protocol. BMC Cancer (2015) 0.84
Transperitoneal approach versus retroperitoneal approach: a meta-analysis of laparoscopic partial nephrectomy for renal cell carcinoma. PLoS One (2014) 0.83
Hydrogen sulfide treatment ameliorates long-term renal dysfunction resulting from prolonged warm renal ischemia-reperfusion injury. Can Urol Assoc J (2014) 0.83
Incidence trends of urinary bladder and kidney cancers in urban Shanghai, 1973-2005. PLoS One (2013) 0.82
Renal cell carcinoma: links and risks. Int J Nephrol Renovasc Dis (2016) 0.81
Lead, calcium uptake, and related genetic variants in association with renal cell carcinoma risk in a cohort of male Finnish smokers. Cancer Epidemiol Biomarkers Prev (2011) 0.81
Renal transplantation with kidneys affected by tumours. Int J Nephrol (2011) 0.81
Diagnostic Accuracy and Risks of Biopsy in the Diagnosis of a Renal Mass Suspicious for Localized Renal Cell Carcinoma: Systematic Review of the Literature. J Urol (2016) 0.80
Indirect comparisons of efficacy and safety between seven newer targeted agents for metastatic renal cell carcinoma: A network meta-analysis of randomised clinical trials. Mol Clin Oncol (2014) 0.80
The use of partial nephrectomy: results from a contemporary national prospective multicenter study. World J Urol (2014) 0.80
The role of radiologic imaging and biopsy in renal tumor ablation. World J Urol (2010) 0.79
MicroRNA-194 is a Marker for Good Prognosis in Clear Cell Renal Cell Carcinoma. Cancer Med (2016) 0.79
Metastatic renal cell carcinoma: update on epidemiology, genetics, and therapeutic modalities. Immunotargets Ther (2013) 0.79
Risk of metastasis for T1a renal cell carcinoma. World J Urol (2015) 0.78
One-carbon metabolism pathway gene variants and risk of clear cell renal cell carcinoma in a Chinese population. PLoS One (2013) 0.78
IMA901: a multi-peptide cancer vaccine for treatment of renal cell cancer. Hum Vaccin Immunother (2014) 0.78
In vivo, percutaneous, needle based, optical coherence tomography of renal masses. J Vis Exp (2015) 0.78
Ablative therapies for renal tumors. Ther Adv Urol (2010) 0.77
Kidney cancer mortality in Spain: geographic patterns and possible hypotheses. BMC Cancer (2008) 0.77
18-F fluorodeoxyglucose uptake in positron emission tomography as a pathological grade predictor for renal clear cell carcinomas. Eur Radiol (2015) 0.77
Renal cell carcinoma presenting as an ominous metachronous scalp metastasis. Can Urol Assoc J (2010) 0.77
Time trend and age-period-cohort effect on kidney cancer mortality in Europe, 1981-2000. BMC Public Health (2006) 0.77
The epigenetic modifier CHD5 functions as a novel tumor suppressor for renal cell carcinoma and is predominantly inactivated by promoter CpG methylation. Oncotarget (2016) 0.76
A multicentre phase II trial of bryostatin-1 in patients with advanced renal cancer. Br J Cancer (2003) 0.76
Thermoablation of Renal Masses: The Urologist's Perspective. Semin Intervent Radiol (2011) 0.76
Low C24-OH and C22-OH sulfatides in human renal cell carcinoma. J Mass Spectrom (2014) 0.76
Small-area spatio-temporal analyses of bladder and kidney cancer risk in Nova Scotia, Canada. BMC Public Health (2016) 0.75
The association between fish consumption and risk of renal cancer: a meta-analysis of observational studies. PLoS One (2013) 0.75
A commentary on "risk factors for renal cell cancer in a Japanese population". Clin Med Oncol (2009) 0.75
Irreversible Electroporation for the Ablation of Renal Cell Carcinoma: A Prospective, Human, In Vivo Study Protocol (IDEAL Phase 2b). JMIR Res Protoc (2017) 0.75
Utilization and perioperative complications of laparoscopic cryoablation vs. robotic partial nephrectomy for localized renal tumors. Int Braz J Urol (2015) 0.75
Combined use of COX-1 and VEGF immunohistochemistry refines the histopathologic prognosis of renal cell carcinoma. Int J Clin Exp Pathol (2015) 0.75
Comparative analysis of radiologically measured size and true size of renal tumors. Korean J Urol (2013) 0.75
Robotic nephron-sparing surgery for renal tumors: Current status. Indian J Urol (2014) 0.75
The type of nephrectomy has little effect on overall survival or cardiac events in patients of 70 years and older with localized clinical t1 stage renal masses. Korean J Urol (2014) 0.75
The epigenetic landscape of clear-cell renal cell carcinoma. J Kidney Cancer VHL (2015) 0.75
Klotho plays a critical role in clear cell renal cell carcinoma progression and clinical outcome. Korean J Physiol Pharmacol (2016) 0.75
Small Incidental Renal Masses in Adults: Review of the literature. Sultan Qaboos Univ Med J (2010) 0.75
Comparison of guideline recommendations with daily practice in patients with renal cell carcinoma. Eur J Med Res (2010) 0.75
The impact of immunohistochemical expression of nitric oxide synthases on clinical and pathological features of renal cell carcinoma. World J Urol (2012) 0.75
American Confederation of Urology (CAU) experience in minimally invasive partial nephrectomy. World J Urol (2016) 0.75
Charlson score as a single pertinent criterion to select candidates for active surveillance among patients with small renal masses. World J Urol (2013) 0.75
Prevalence of baseline chronic kidney disease in 2,769 Chinese patients with renal cancer: nephron-sparing treatment is still underutilized. World J Urol (2014) 0.75
Differences in presentation characteristics of renal cell carcinoma in the last 25 years: a single center experience. J Cancer Res Clin Oncol (2008) 0.75
Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science (1990) 16.68
Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA (1991) 11.53
Cancer burden in the year 2000. The global picture. Eur J Cancer (2001) 10.47
Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer (1998) 10.17
Rising incidence of renal cell cancer in the United States. JAMA (1999) 9.57
Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature (2000) 8.96
Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res (1988) 7.30
Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? Ann Intern Med (1969) 6.54
A cancer family syndrome in twenty-four kindreds. Cancer Res (1988) 6.39
Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. Science (1999) 5.09
The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med (1996) 4.81
Solid cancers after bone marrow transplantation. N Engl J Med (1997) 4.62
Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst (1993) 4.59
Lung cancer. Cancer (1995) 4.50
Snuff dipping and oral cancer among women in the southern United States. N Engl J Med (1981) 4.33
Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst (1997) 4.09
International trends and patterns of prostate cancer incidence and mortality. Int J Cancer (2000) 3.73
Obesity, hypertension, and the risk of kidney cancer in men. N Engl J Med (2000) 3.72
Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst (1998) 3.66
Agricultural herbicide use and risk of lymphoma and soft-tissue sarcoma. JAMA (1986) 3.63
Risk of cancer in renal-transplant recipients. Lancet (1973) 3.36
Cancer risk in users of calcium channel blockers. Hypertension (1997) 3.30
Second cancers after adjuvant tamoxifen therapy for breast cancer. J Natl Cancer Inst (1996) 3.26
An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res (1998) 3.22
A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control (2001) 3.13
Splenectomy and subsequent mortality in veterans of the 1939-45 war. Lancet (1977) 3.05
Cancer incidence and mortality trends in the United States: 1935-74. J Natl Cancer Inst (1978) 3.01
Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. JAMA (1997) 3.00
Clues to cancer etiology from studies of farmers. Scand J Work Environ Health (1992) 2.98
Risk of second malignant neoplasms among long-term survivors of testicular cancer. J Natl Cancer Inst (1997) 2.83
Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst (1996) 2.78
Recent cancer trends in the United States. J Natl Cancer Inst (1995) 2.76
Recent trends in cutaneous melanoma incidence among whites in the United States. J Natl Cancer Inst (2001) 2.73
Continuing climb in rates of esophageal adenocarcinoma: an update. JAMA (1993) 2.71
The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia. JAMA (1995) 2.68
Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer (1999) 2.66
Population attributable risk of renal cell cancer in Minnesota. Am J Epidemiol (1998) 2.65
Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood (1999) 2.65
A population-based case-control study of childhood leukemia in Shanghai. Cancer (1988) 2.59
Contamination of poliovirus vaccines with simian virus 40 (1955-1963) and subsequent cancer rates. JAMA (1998) 2.55
Socioeconomic and racial differences in lung cancer incidence. Am J Epidemiol (1983) 2.54
Arsenic and respiratory cancer in man: an occupational study. J Natl Cancer Inst (1969) 2.50
International trends and patterns of primary liver cancer. Int J Cancer (2001) 2.50
Tobacco use and prostate cancer: 26-year follow-up of US veterans. Am J Epidemiol (1991) 2.49
Geographic patterns of lung cancer: industrial correlations. Am J Epidemiol (1976) 2.45
Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev (1998) 2.43
Cancer surveillance series: recent trends in childhood cancer incidence and mortality in the United States. J Natl Cancer Inst (1999) 2.38
Mobile phone use and glioma risk: comparison of epidemiological study results with incidence trends in the United States. BMJ (2012) 2.38
Cancer surveillance series: non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995. J Natl Cancer Inst (2000) 2.35
Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977-2005. Br J Cancer (2009) 2.33
Prospective study of serum selenium levels and incident esophageal and gastric cancers. J Natl Cancer Inst (2000) 2.32
Excess incidence of squamous cell esophageal cancer among US Black men: role of social class and other risk factors. Am J Epidemiol (2001) 2.30
Rhabdomyosarcoma in children: epidemiologic study and identification of a familial cancer syndrome. J Natl Cancer Inst (1969) 2.30
Declining lung cancer rates among young men and women in the United States: a cohort analysis. J Natl Cancer Inst (1989) 2.28
Cancer mortality among chemists. J Natl Cancer Inst (1969) 2.28
Association of breast cancer and cervical cancer incidence with income and education among whites and blacks. J Natl Cancer Inst (1980) 2.21
Acute leukemia after alkylating-agent therapy of ovarian cancer. N Engl J Med (1977) 2.20
Fluoridated drinking water and the occurrence of cancer. J Natl Cancer Inst (1976) 2.19
A population--based case--control study of renal cell carcinoma. J Natl Cancer Inst (1984) 2.17
Trends and patterns of prostate cancer: what do they suggest? Epidemiol Rev (2001) 2.14
Multiple primary cancers in families with Li-Fraumeni syndrome. J Natl Cancer Inst (1998) 2.13
Nutrient intake and risk of subtypes of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev (2001) 2.13
Alcohol dehydrogenase 3 genotype and risk of oral cavity and pharyngeal cancers. J Natl Cancer Inst (1997) 2.12
Leukemia after therapy with alkylating agents for childhood cancer. J Natl Cancer Inst (1987) 2.12
Melanomas of the eye and other noncutaneous sites: epidemiologic aspects. J Natl Cancer Inst (1976) 2.11
Risk factors for esophageal cancer in Shanghai, China. I. Role of cigarette smoking and alcohol drinking. Int J Cancer (1994) 2.09
Risk of urinary tract cancers following kidney or ureter stones. J Natl Cancer Inst (1997) 2.06
Synthetic sweetener consumption and bladder cancer trends in the United States. Nature (1970) 2.05
The influence of cigarette smoking, alcohol, and green tea consumption on the risk of carcinoma of the cardia and distal stomach in Shanghai, China. Cancer (1996) 2.05
Geographic patterns of oral cancer in the United States: etilogic implications. J Chronic Dis (1977) 2.02
Cancer incidence and mortality trends among whites in the United States, 1947-84. J Natl Cancer Inst (1987) 2.02
Solid tumors after chronic lymphocytic leukemia. Blood (2001) 2.01
Demographic patterns for mesothelioma in the United States. J Natl Cancer Inst (1987) 2.01
Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer. Cancer Causes Control (2000) 2.00
Passive smoking and lung cancer. J Natl Cancer Inst (1986) 1.99
Smoking, air pollution, and the high rates of lung cancer in Shenyang, China. J Natl Cancer Inst (1989) 1.99
A population-based case-control study of thyroid cancer. J Natl Cancer Inst (1987) 1.98
Epidemiology of uterine cervical cancer. J Chronic Dis (1986) 1.97
Epidemiology of human leukemia: recent observations. J Natl Cancer Inst (1967) 1.97
Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers. Cancer Epidemiol Biomarkers Prev (2001) 1.95
Indoor radon and lung cancer in China. J Natl Cancer Inst (1990) 1.95
Dietary and nutritional factors and pancreatic cancer: a case-control study based on direct interviews. J Natl Cancer Inst (1998) 1.91
Follow-up study of twenty-four families with Li-Fraumeni syndrome. Cancer Res (1991) 1.89
Gallstones and the risk of biliary tract cancer: a population-based study in China. Br J Cancer (2007) 1.87
Incidence of colorectal carcinoma in the U.S.: an update of trends by gender, race, age, subsite, and stage, 1975-1994. Cancer (1999) 1.84
Lung cancer among Chinese women. Int J Cancer (1987) 1.83
Tobacco and alcohol use and oral cancer in Puerto Rico. Cancer Causes Control (1999) 1.83
Cancer incidence trends in urban shanghai, 1972-1994: an update. Int J Cancer (1999) 1.83
Lung cancer after employment in shipyards during World War II. N Engl J Med (1978) 1.82
Non-Hodgkin's lymphoma among people with AIDS: incidence, presentation and public health burden. AIDS/Cancer Study Group. Int J Cancer (1997) 1.82
Breast cancer risk factors among screening program participants. J Natl Cancer Inst (1979) 1.81
Racial differences in risk of oral and pharyngeal cancer: alcohol, tobacco, and other determinants. J Natl Cancer Inst (1993) 1.80
Second cancers in patients with chronic lymphocytic leukemia. J Natl Cancer Inst (1992) 1.79